[EN] HETEROCYCLIC INHIBITORS OF TEAD FOR TREATING CANCER<br/>[FR] INHIBITEURS HÉTÉROCYCLIQUES DE TEAD POUR LE TRAITEMENT DU CANCER
申请人:GENENTECH INC
公开号:WO2022020716A1
公开(公告)日:2022-01-27
The invention relates to compounds and methods of using said compounds, as well as pharmaceutical compositions containing such compounds, for treating diseases and conditions mediated by TEAD, such as cancer.
Phosphonothrixin (1) is a novel herbicidalagent produced by Saccharothrix sp. ST-888, with a unique structure possessing a C-P bond and an isoprene unit. The total synthesis of this antibiotic was accomplished from methyl (bromomethyl)acrylate in six steps.